ENTITY

Jounce Therapeutics (JNCE US)

Health Care • United States

Jounce Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and discovers immunotherapy drugs for cancer patients. Jounce Therapeutics serves customers in the United States.

Refresh

Focused

No publications yet

Add Jounce Therapeutics to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00